Medplus Health Services Ltd Stock Price Today (NSE: MEDPLUS)

Medplus Health Services Ltd

900.15+25.50 (+2.92%)
Market Closed

Fundamental Score

...

Medplus Health Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Medplus Health Services Ltd share price today is 900.15, up +2.92% on NSE/BSE as of 19 June 2026. Medplus Health Services Ltd (MEDPLUS) is a Mid-cap company in the Pharmacy Retail sector with a market capitalisation of 9.71K (Cr). The 52-week high for MEDPLUS share price is 1022.20 and the 52-week low is 732.00. At a P/E ratio of 49.79x, MEDPLUS is currently trading above its industry average P/E of 45.55x. The company has a Return on Equity (ROE) of 8.80% and a debt-to-equity ratio of 0.65.

Medplus Health Services Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
1022.20
Low
852.20
Volume
2.3L
Change
-2.01%

Medplus Health Services Ltd share price chart: -2.01% return over the past month. 52-week high ₹1022.20, 52-week low ₹732.00.

Medplus Health Services Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
870.10909.35865.90900.151.62L (Cr)
890.00895.00865.00874.651.68L (Cr)
881.95905.15877.90895.202.39L (Cr)
881.85881.85881.85881.850.00 (Cr)
882.95888.95863.00881.851.44L (Cr)
864.00913.00864.00882.452.79L (Cr)
900.00908.00876.45896.952.52L (Cr)
953.90972.00892.35898.753.04L (Cr)
975.001022.20941.20953.9020.59L (Cr)
936.00951.00901.45910.801.88L (Cr)

Medplus Health Services Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
890.00909.35865.00900.15+1.14%
872.151022.20852.20895.20+2.64%
844.05916.00814.00872.15+3.33%
802.60858.90793.40839.90+4.65%
811.80905.00804.25847.60+4.41%
805.00854.90759.00798.95-0.75%
810.95829.90785.15807.30-0.45%
787.00868.00749.45808.80+2.77%
752.95797.45732.00762.85+1.31%
841.95858.60746.60757.45-10.04%
931.00940.00800.55841.95-9.56%
900.05945.00843.80930.55+3.39%

Returns & Performance

Poor

Return on Equity (ROE)

8.80%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

10.28%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

6.90%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Medplus Health Services Ltd Valuation Check

Poor

Price to Earnings (P/E)

49.79x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

45.55x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

40.29%

% shares held by company founders/management

Good

FII Holding

16.53%

% shares held by foreign institutional investors

Excellent

DII Holding

26.51%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

59.34%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

43.26%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

6.54%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

16.41%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-35.35%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

131.42%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.65x

Total debt ÷ equity. Below 0.5 = financially healthy

Good

Interest Coverage Ratio

3.20x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

469.03 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Medplus Health Services Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MEDPLUS across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Robust Profit Growth (43.26%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (16.41% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (131.42% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Cash Generation (₹469.03 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 43.04%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

5 factors identified

Below-Average Return on Equity (8.80%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Premium Valuation Risk (P/E: 49.79x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Weak Earnings Growth (-35.35% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

High Share Pledging Risk (59.34%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Medplus Health Services Ltd vs Pharmacy Retail Peers

Peer Comparison - Pharmacy Retail

Compare Medplus Health Services Ltd with 1 other companies in the same sector

2 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
30.9/100
900
₹9713.43
49.8
Average
8.80%
Poor
10.28%
Average
0.7
Good
131.42%
Excellent
16.41%
Excellent
0.00%
56.9/100
1185
₹4566.30
41.3
Average
5.63%
Poor
8.71%
Poor
0.3
Excellent
151.54%
Excellent
30.44%
Excellent
0.00%

Medplus Health Services Ltd PE Ratio History

Historical price-to-earnings ratio for MEDPLUS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202512.52₹807.3064.5x
FY 20245.45₹830.85152.4x
FY 20234.17₹750.75180x
FY 20228.52₹613.6072x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Medplus Health Services Ltd Quarterly Performance

Latest quarterly metrics for MEDPLUS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

6.54%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

43.26%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

16.41%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

131.42%

Compounded annual net profit growth over 5 years

Medplus Health Services Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MEDPLUS — calculated from daily price history

50RSI 14
Neutral — RSI 50

Momentum is balanced — neither overbought nor oversold.

SMA 50
869
▲ Price above SMA 50 — Short-term bullish
SMA 200
827
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
188K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Medplus Health Services Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Medplus Health Services Ltd (MEDPLUS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Medplus Health Services Ltd

About MEDPLUS (Medplus Health Services Ltd)

Medplus Health Services Ltd is a ubiquitous presence in the Indian pharmacy retail landscape, distinguished by its extensive network of strategically located stores. More than just... a place to purchase medication, Medplus offers a comprehensive healthcare destination. Shelves are stocked with an array of pharmaceuticals, ranging from essential prescription drugs to readily available over-the-counter remedies. Beyond traditional medicines, Medplus caters to a growing health-conscious consumer base by providing a wide selection of wellness products, including vitamins, nutritional supplements, and medical devices designed for home use. This commitment to diverse product offerings positions Medplus as a one-stop shop for individuals seeking both curative and preventative healthcare solutions. The reach of Medplus extends beyond prescription fulfillment and over-the-counter sales. The company has diversified its offerings to include fast-moving consumer goods, recognizing the convenience and value of integrating everyday household essentials into its retail environment. Customers can find a variety of personal care items, such as toiletries, soaps, and sanitizers, alongside baby care products and cleaning supplies. This strategic inclusion of FMCG items enhances the shopping experience, making Medplus a convenient location for customers to address multiple needs in a single trip. The company's commitment to quality and value ensures that customers have access to reliable and affordable products across all categories. Beyond its retail presence, Medplus operates a wholesale division, catering to smaller pharmacies and healthcare providers through a cash-and-carry model. This business segment contributes to the broader accessibility of pharmaceuticals and healthcare products across the Indian market. In addition to product sales, Medplus also offers diagnostic services, further solidifying its position as a comprehensive healthcare provider. This multifaceted approach, encompassing retail, wholesale, and diagnostic services, sets Medplus apart in the competitive pharmacy retail sector, offering a holistic approach to meeting the diverse healthcare needs of its customers.

Company Details

Symbol:MEDPLUS
Industry:Pharmacy Retail
Sector:Pharmacy Retail

Key Leadership

Dr. Gangadi Madhukar Reddy
Founder, CEO, MD & Chairman
Mr. Sujit Kumar Mahato
Chief Financial Officer
Dr. Cherukupalli Bhaskar Reddy
COO & Whole Time Director

MEDPLUS Share Price: Frequently Asked Questions

What is the current share price of Medplus Health Services Ltd?

Medplus Health Services Ltd (MEDPLUS) trades at ₹900.15 on NSE and BSE. Market cap ₹9.71K (Cr). Educational data only.

What is the P/E ratio of Medplus Health Services Ltd?

Medplus Health Services Ltd has a P/E of 49.79x vs industry average 45.55x.

What is the Bull Run score for Medplus Health Services Ltd?

Medplus Health Services Ltd has a Bull Run score of 30.9/100 based on 25+ financial parameters.

Does Medplus Health Services Ltd pay dividends?

Medplus Health Services Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Medplus Health Services Ltd?

Medplus Health Services Ltd has ROE of 8.80%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Medplus Health Services Ltd?

Medplus Health Services Ltd has debt-to-equity of 0.65.

Is Medplus Health Services Ltd a good investment?

Bull Run gives Medplus Health Services Ltd a score of 30.9/100. This is not investment advice — consult a SEBI-registered advisor.